Nexentis Technologies Inc. (NXTS) - Total Liabilities
Based on the latest financial reports, Nexentis Technologies Inc. (NXTS) has total liabilities worth $16.91 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See NXTS days of operational coverage to measure how many days the company can operate on defensive assets alone.
Nexentis Technologies Inc. - Total Liabilities Trend (2009–2025)
This chart illustrates how Nexentis Technologies Inc.'s total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Nexentis Technologies Inc. to evaluate the company's liquid asset resilience ratio.
Nexentis Technologies Inc. Competitors by Total Liabilities
The table below lists competitors of Nexentis Technologies Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bone Biologics Corp
NASDAQ:BBLG
|
USA | $512.02K |
|
Yida China Holdings Ltd
STU:YC2
|
Germany | €26.29 Billion |
|
Uniinfo Telecom Services Limited
NSE:UNIINFO
|
India | Rs99.34 Million |
|
Ellen AB (publ)
ST:ELN
|
Sweden | Skr4.67 Million |
|
Asia Pacific Investama Tbk PT
JK:MYTX
|
Indonesia | Rp4.05 Trillion |
|
JZ Capital Partners Ltd
LSE:JZCP
|
UK | GBX570.00K |
|
Iofina plc
LSE:IOF
|
UK | GBX23.53 Million |
|
INFINITII AI INC.
F:Y31
|
Germany | €2.30 Million |
Liability Composition Analysis (2009–2025)
This chart breaks down Nexentis Technologies Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NXTS current and non-current assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nexentis Technologies Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nexentis Technologies Inc. (2009–2025)
The table below shows the annual total liabilities of Nexentis Technologies Inc. from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.67 Million | +424.10% |
| 2024-12-31 | $892.00K | +13.54% |
| 2023-12-31 | $785.65K | +4.08% |
| 2022-12-31 | $754.87K | -36.28% |
| 2021-12-31 | $1.18 Million | +2.74% |
| 2020-12-31 | $1.15 Million | +8.09% |
| 2019-12-31 | $1.07 Million | +64.71% |
| 2018-12-31 | $647.70K | -48.91% |
| 2017-12-31 | $1.27 Million | -0.68% |
| 2016-12-31 | $1.28 Million | +15.27% |
| 2013-12-31 | $1.11 Million | -7.65% |
| 2012-12-31 | $1.20 Million | +113.98% |
| 2011-12-31 | $560.36K | -19.94% |
| 2010-12-31 | $699.93K | +80.90% |
| 2009-12-31 | $386.92K | -- |
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model… Read more